Klothea Bio, Inc.
PrivateLast Round
Seed
Nov 25, 2024
Company Overview
Klothea Bio, Inc. operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Seed round in November 2024.
Klothea Bio, Inc. is a biotechnology company developing next-generation longevity therapeutics aimed at delaying age-related diseases by using a proprietary mRNA platform to boost endogenous secretion of the Klotho protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klothea Bio, Inc. Comparables
Compare Klothea Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rejuvenation Technologies | 82% | |
| Jocasta Neuroscience | 79% | |
| Turn Biotechnologies | 73% |
For institutional investors. Book with your work email.
Klothea Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 25, 2024 | ||||
| Seed Round | Oct 11, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Klothea Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 11, 2024
Raised $7M in a seed funding round.
For institutional investors. Book with your work email.
Klothea Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Klothea Bio, Inc.'s valuation, stock price, and market status.
Is Klothea Bio, Inc. a public or private company?
Klothea Bio, Inc. is a private company.
What is the current stock price of Klothea Bio, Inc.?
Klothea Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Klothea Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Klothea Bio, Inc. worth (valuation)?
Valuation information for Klothea Bio, Inc. is not publicly available.
Can I buy Klothea Bio, Inc. stock?
Klothea Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Klothea Bio, Inc.'s last funding round?
Klothea Bio, Inc.'s most recent funding round was Seed on November 25, 2024.
Who are the main investors in Klothea Bio, Inc.?
Key investors in Klothea Bio, Inc. include Longevitytech.fund.
Will Klothea Bio, Inc. IPO soon?
No public IPO plans have been announced for Klothea Bio, Inc..
How can I track Klothea Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Klothea Bio, Inc.'s shares on secondary markets.